A vs APRE: Which Stock is Better?
Side-by-side comparison of Agilent Technologies Inc and Aprea Therapeutics Inc in 2026
A
Agilent Technologies Inc
$117.50
APRE
Aprea Therapeutics Inc
$0.85
Key Metrics Comparison
| Metric | A | APRE | Winner |
|---|---|---|---|
| Market Cap | $32.54B | $10.50M | A |
| P/E Ratio | 25.40 | N/A | A |
| EPS (TTM) | $4.53 | $N/A | A |
| Revenue Growth | 0.1% | -1.0% | A |
| Gross Margin | 52.3% | -2364.7% | A |
Analyze A
Full quant analysis
Analyze APRE
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is A or APRE a better investment?
Comparing A and APRE: Agilent Technologies Inc has a market cap of $32.54B while Aprea Therapeutics Inc has $10.50M. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between A and APRE?
A (Agilent Technologies Inc) and APRE (Aprea Therapeutics Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: A or APRE?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: A or APRE?
A has higher revenue growth at 0.1% vs -1.0% for APRE.
Which company is more profitable: A or APRE?
Agilent Technologies Inc (A) has higher gross margins at 52.3% compared to -2364.7% for APRE.
Which is the larger company: A or APRE?
Agilent Technologies Inc (A) is larger with a market cap of $32.54B compared to $10.50M for APRE.
Should I buy A or APRE in 2026?
Both A and APRE have investment merit. A trades at $117.50 while APRE trades at $0.85. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between A and APRE stock?
Key differences: Market Cap ($32.54B vs $10.50M), P/E Ratio (25.4x vs N/A), Revenue Growth (0.1% vs -1.0%), Gross Margin (52.3% vs -2364.7%).